Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Pharmaceutical Design, Volume 17 - Number 19


The Urokinase Receptor Interactome

, 17(19): 1874 - 1889

Gabriele Eden, Marco Archinti, Federico Furlan, Ronan Murphy and Bernard Degryse


DOI: 10.2174/138161211796718215


Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients

, 17(19): 1890 - 1910

Martin C. Boonstra, Hein W. Verspaget, Sjam Ganesh, Frank J.G.M. Kubben, Alexander L. Vahrmeijer, Cornelis J.H. van de Velde, Peter J.K. Kuppen, Paul H.A. Quax and Cornelis F.M. Sier


DOI: 10.2174/138161211796718233










Editor-in-Chief

Alessandro Antonelli
Laboratory of Primary Human Cells
University of Pisa
Pisa
(Italy)

Biography
View Full Editorial Board

Executive Editor

Atta-ur-Rahman, FRS
(29381 citations)
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
(UK)
Biography

View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Journal History

Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks.
Scopus CiteScore Metrics: 2.32

Advertisement

October Health DaysPLANNING YOUR RESEARCH TO PUBLISH IN HIGH IMPACT JOURNALSCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog